Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
Clinical trial NCT05403541 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05403541
- Sponsor
- Immunovant Sciences GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-27
- Primary completion
- 2025-01-10
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.